All products are provided on an as-is basis without warranties, express or implied
The seven drugs that are currently considered GLP-1 receptor agonists include: Dulaglutide (Trulicity) Tirzepatide (Mounjaro, Zepbound) Exenatide extended-release (Bydureon) Exenatide (Byetta) Semaglutide injection (Ozempic, Wegovy) Semaglutide tablet (Rybelsus) Liraglutide (Victoza, Saxenda) Lixisenatide (Adlyxin) If all of these drugs influence GLP-1 in similar ways, what makes each of them unique
Not all of it, but meaningful retention
The concern is consistency
Aim for at least 30 minutes of moderate exercise most days of the week
The GLP-1 receptor activation promotes insulin secretion in a glucose-dependent manner, slows gastric emptying, and reduces appetite through central nervous system pathways